Safety and immunogenicity of a combined DTPa–IPV vaccine administered as a booster from 4 years of age: A review
Year: 2005
Type: article
Source: Vaccine
Institutions: GlaxoSmithKline (Belgium), Hôpital Armand-Trousseau, Hôpital Intercommunal de Créteil, Norwegian Institute of Public Health, Örebro University Hospital, University of Bologna, The University of Melbourne, Murdoch Children's Research Institute, The University of Western Australia, The University of Adelaide
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2080572050
